Product NDC: | 43063-225 |
Proprietary Name: | Primaquine Phosphate |
Non Proprietary Name: | Primaquine Phosphate |
Active Ingredient(s): | 26.3 mg/1 & nbsp; Primaquine Phosphate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 43063-225 |
Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA008316 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100101 |
Package NDC: | 43063-225-28 |
Package Description: | 28 TABLET in 1 BOTTLE, PLASTIC (43063-225-28) |
NDC Code | 43063-225-28 |
Proprietary Name | Primaquine Phosphate |
Package Description | 28 TABLET in 1 BOTTLE, PLASTIC (43063-225-28) |
Product NDC | 43063-225 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Primaquine Phosphate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20100101 |
Marketing Category Name | ANDA |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Substance Name | PRIMAQUINE PHOSPHATE |
Strength Number | 26.3 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Antimalarial [EPC] |